TAILored Versus COnventional AntithRombotic StratEgy IntenDed for Complex HIgh-Risk PCI — TAILORED-CHIP

Coronary Stenoses Clinical Trial

Official title:
Comparison of Tailored Antiplatelet Therapy With Early Escalation and Late De-Escalation Strategy Versus Standard Dual Antiplatelet Therapy in Patients Undergoing Complex High-Risk Percutaneous Coronary Intervention

Status Active, not recruiting

Clinical Trial Summary

This study evaluates the efficacy and safety of tailored antithrombotic therapy with early (<6-month post-PCI) intensified (low-dose ticagrelor [120 mg loading, then 60 mg bid maintenance] and aspirin) and late (>6-month post-PCI) deescalated (clopidogrel alone) strategy in patients undergoing high-risk complex PCI as compared with standard Dual Antiplatelet Therapy(aspirin and clopidogrel for 12 months).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03465644
Study type	Interventional
Source	Asan Medical Center
Contact
Status	Active, not recruiting
Phase	Phase 4
Start date	February 12, 2019
Completion date	January 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02951949` - Estrogen Exposure and Atherosclerosis in Postmenopausal Women
Enrolling by invitation	`NCT02931331` - Coronary Revascularization Assessed by Stress PET	N/A
Active, not recruiting	`NCT02978456` - Quantitative Coronary Angiography Versus Intravascular Ultrasound GUIDancE for Drug-Eluting Stent Implantation	N/A